Healthcare
Tuesday, January 17, 2017
BRIEF-Biolinerx announces initiation of Immuno-oncology Phase 2 study
* Biolinerx announces initiation of Immuno-oncology Phase 2
study to investigate combination of BL-8040 and keytruda for
pancreatic cancer
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment